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When inferring networks from high-throughput genomic data, one of the main challenges
is the subsequent validation of these networks. In the best case scenario, the true network
is partially known from previous research results published in structured databases
or research articles. Traditionally, inferred networks are validated against these known
interactions. Whenever the recovery rate is gauged to be high enough, subsequent
high scoring but unknown inferred interactions are deemed good candidates for further
experimental validation. Therefore such validation framework strongly depends on the
quantity and quality of published interactions and presents serious pitfalls: (1) availability
of these known interactions for the studied problem might be sparse; (2) quantitatively
comparing different inference algorithms is not trivial; and (3) the use of these known
interactions for validation prevents their integration in the inference procedure. The
latter is particularly relevant as it has recently been showed that integration of priors
during network inference significantly improves the quality of inferred networks. To
overcome these problems when validating inferred networks, we recently proposed a
data-driven validation framework based on single gene knock-down experiments. Using
this framework, we were able to demonstrate the benefits of integrating prior knowledge
and expression data. In this paper we used this framework to assess the quality of
different sources of prior knowledge on their own and in combination with different
genomic data sets in colorectal cancer. We observed that most prior sources lead to
significant F -scores. Furthermore, their integration with genomic data leads to a significant
increase in F -scores, especially for priors extracted from full text PubMed articles, known
co-expression modules and genetic interactions. Lastly, we observed that the results are
consistent for three different data sets: experimental knock-down data and two human
tumor data sets.
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1. INTRODUCTION
Whilst it is now widely accepted that cellular processes are
in general not only governed by single genes but instead also
by networks of interacting genes (Barabási and Oltvai, 2004),
there is no gold-standard for validating these biological net-
works (Yngvadottir et al., 2009; Fernald et al., 2011). However,
as network inference is increasingly used in biomedical research
such as drug discovery or disease classification (Barabási et al.,
2011), also the subsequent validation needs to be revisited.
The most commonly used approach consists in comparing the
inferred network to known interactions stored in biological
databases and research articles (Altay et al., 2013). However, this
approach has three major drawbacks: Firstly, these interactions
are rarely complete, secondly they might not be appropriate for
the studied problem and lastly, their quality has not yet been
evaluated.
An alternative use for this prior knowledge is its integra-
tion into the network inference algorithms in order to improve
the quality of inferred networks. Indeed, we and others showed
that the combination of data and prior knowledge significantly
improves the quality of networks compared to networks inferred
from data only (Djebbari and Quackenbush, 2008; Mukherjee
and Speed, 2008; Olsen et al., 2014). However, if prior knowl-
edge is used to improve the inference process its subsequent use
in the quality assessment would dramatically increase the risk of
overfitting.
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Recently, we proposed a purely data-driven approach relying
on experimental perturbation data to identify the set of relevant
genes for a given problem (Olsen et al., 2014). This validation
framework not only provides the possibility to compare different
inference algorithms but furthermore allows us to independently
assess different sources of prior knowledge by themselves and in
combination with expression data.
In this follow-up paper to Olsen et al. (2014), we use the
proposed validation framework to evaluate the quality of a vari-
ety of prior sources, both in combination with different pub-
licly available tumor data sets and by themselves. We retrieved
the prior knowledge using the two web applications Predictive
Networks (Haibe-Kains et al., 2012b) andGeneMANIA (Mostafavi
et al., 2008), for a total of eight different sources. After the assess-
ment of the different prior sources’ quality, we infer networks
using three different microarray data sets: experimental knock-
down data from cell line experiments and two publicly available
human tumor data sets. We quantitatively assess their quality
through the estimation of F-scores, a well established quality
metrics in network inference.
We observe that most prior sources lead to significant F-scores.
Their integration with genomic data leads to a significant increase
in F-scores, especially for priors extracted from full text PubMed
articles, known co-expression modules and genetic interactions.
We also observe that the results are consistent for three differ-
ent data sets: experimental knock-down data and two human
tumor data sets. Furthermore, we observe that combining dif-
ferent sources can be beneficial compared to using a single prior
source.
2. MATERIALS AND METHODS
2.1. METHOD—VALIDATION OF INFERRED NETWORKS
The best case scenario in most real-world application is partial
knowledge of the true, data-generating network. Therefore, the
assessment of any inferred network cannot depend on this knowl-
edge alone. As an alternative, we proposed a purely data-driven
validation framework proposed in Olsen et al. (2014). This val-
idation framework depends on the availability of experimental
intervention data such as knock-down experiments. This type of
data allows us, for each knock-down experiment separately, to
statistically evaluate whether or not a gene in the data set was
significantly affected by the experiment. In this case, this rela-
tion should be reflected in any inferred network in the sense
that the affected gene can be found downstream of the knocked
down gene. This in turn then allows us to quantitatively assess
the quality of inferred gene interaction networks by computing
quality measures such as precision, recall or F-score (Sokolova
et al., 2006). The outline of the framework is depicted in Figure 1.
Suppose that a number of single gene knock-down experiments
were carried out. Then one can use these experiments in a five
step procedure:
1. Select a single knock-down and all corresponding replicates
from the collection.
2. Use these samples to determine the set of genes that were sig-
nificantly affected by the perturbation experiments by means
of statistical tests.
FIGURE 1 | Quantitative validation framework for network inference.
The framework relies on a set of single-gene knock-down experiments in a
leave-one-out cross-validation scheme.
3. Use the remaining independent samples to infer a directed
network.
4. Classify the knock-down’s descendants (in the inferred net-
work) into true positives, false positives and false negatives
with respect to the affected genes identified in step 2. The
descendants of a node in the network are defined to be the set
of its children and grandchildren.
5. Repeat steps 1–4 until all perturbations have been used to
assess the network’s local predictive power.
In Olsen et al. (2014), a network was inferred from the sam-
ples not related to the single knock-down experiment (step
3). However, in the same article it was shown that these
knock-down samples from cell line experiments can be used
for validation not only in such a cross-validation scheme
but also for networks inferred from independent tumor sam-
ples, which demonstrates the generalizability of our validation
approach.
The classification of the nodes in the network (step 4) follows
the rationale that statistically significantly affected genes should
be found in a directed network downstream of the perturbed
gene, its descendants (Figure 1). Therefore all genes in the set
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of descendants which are significantly affected by the perturba-
tion can be classified as true positives (TP) and all significantly
affected genes that are inferred outside of the set of descendants
as false negatives (FN). Genes that are part of the descendants
in the inferred network but are not significantly affected by the
perturbation are then false positives (FP).
This classification then allows us to compute the F-score, the
harmonic average of precision and recall
F = 2 · TP
2 · TP + FP + FN ∈ [0, 1], (1)
where F = 0 corresponds to no correctly identified affected genes
and F = 1 corresponds to perfect classification.
To control for the density of the network and thus guarantee-
ing that the F-scores are meaningful, we generated 1000 random
networks. Each random network is obtained from the inferred
network by shuffling the genes in this network.
2.2. MATERIAL—DATA
Throughout this study, we use the perturbation data described
in Olsen et al. (2014), which are publicly available in the NCBI
Gene Expression Omnibus (GEO) repository (Barrett et al.,
2005), under accession number GSE53091. The samples of this
data set consist of eight single gene knock-downs, namely CDK5,
HRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, NGFR, and RAF1.
These genes belong to the RAS signaling pathway which has
been showed to play a key role in colorectal cancer (Zenonos
and Kyprianou, 2013). The knockdown experiments were per-
formed in two colon cancer cell lines, SW480 and SW620 (NCBI
Gene Expression Omnibus (GEO) repository (Barrett et al., 2005)
accession number GSE53091). For each knock-down, six biolog-
ical replicates were obtained together with controls in both cell
lines, in total 125 samples. The data set furthermore consists of
the 339 variables over expressing RAS as identified in Bild et al.
(2005) and used in Olsen et al. (2014).
For each of the knocked down genes we identify the
significantly affected genes by comparing the expression of
genes in control versus those of the knock-down experi-
ments with a Wilcoxon Rank Sum test, using a false dis-
covery rate (FDR, Benjamini and Hochberg, 1995) <10% as
a threshold for statistical significance. In Table 1 we present
the number of affected genes for each of the knock-down
experiments.
We will use two publicly available tumor cancer data
sets (expO, 2009; Jorissen et al., 2010) to infer the networks. The
first data set (expO) contains 292 human tumor samples and is
Table 1 | Number of genes significantly affected by KD (out of 339
genes) based on gene expression data with FDR <10%.
KD CDK5 HRAS MAP2K1 MAP2K2
Number of affected genes 73 122 33 38
MAPK1 MAPK3 NGFR RAF1
117 59 99 61
accessible from GEO under accession number GSE2109. The sec-
ond (jorissen) data contains 290 samples and is accessible from
GEO under accession number GSE14333.
2.3. MATERIAL—SOURCES OF PRIOR KNOWLEDGE
Possible sources of prior knowledge are manifold and include
published articles, interactions stored in biological databases or
similarity of gene expression values, also referred to as gene
co-expression, from published data sets. To efficiently access
this information a number of different tools have been imple-
mented including GeneMANIA (Mostafavi et al., 2008) and
Predictive Networks (Haibe-Kains et al., 2012a). The former
allows to upload a set of genes and returns a network of the
known interactions distinguishable by source (Table 2) whereas
the latter uses text mining to retrieve known interactions from
PubMed abstracts and furthermore queries structured biolog-
ical databases. Both tools allow to download the interactions
as flat text files, which enables further use of these priors into
advanced genomic analyses such as gene interaction network
inference.
Here we will use the complete prior set retrieved by Predictive
Networks (PN) and priors separated by source fromGeneMANIA.
The different number of known interactions identified by each
tool and source are presented in Table 2. These can be roughly
grouped into three categories: (1) Co-expression and genetic
with >1000 interactions; (2) PN and co-local, pathway and
shared with 100 to ∼400 interactions; and (3) physical and
predicted with<50 interactions.
3. RESULTS
In this section we use the proposed validation framework
(Figure 1) to independently assess the quality of the different pri-
ors retrieved with Predictive Networks and GeneMANIA (Table 2)
in isolation and in combination with three different genomic
data sets.
We use the inference procedure introduced in Haibe-Kains
et al. (2012a,b) which is a two-step procedure implemented in
the R/Bioconductor package predictionet. The first step is a fea-
ture selection step based on theminimum redundancy, maximum
relevance (mRMR, Ding and Peng, 2005; Meyer et al., 2007) cri-
terion whose robustness is improved by the integration of prior
knowledge. The subsequent step is an arc orientation procedure
using a criterion based on interaction information (McGill, 1954)
in which prior integration is used to help orient the edges which
could not be oriented from the genomic data. Given the central
role of priors in predictionet, we implemented a hyperparame-
ter, referred to as prior weight (w), enabling users to tune their
confidence in the prior knowledge incorporated into the network
inference procedure. Prior weight w can take value from 0 to 1;
low w stands for low confidence in prior data. Note that w = 0
forces predictionet to ignore priors (only genomic data are taken
into account), while predictionet with w = 1 will infer networks
solely based on prior information, therefore ignoring genomic
data.
We use each of the three different data sets (kd, expO
and jorissen) to build networks integrating the different
prior knowledge sources with different prior weights w ∈
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Table 2 | Specifications of prior knowledge retrieval tools:
GeneMANIA (GM) and Predictive Networks (PN).
Tool Source # interactions
PN PubMed and databases (PN) 419
Co-expr (GM2) 2760
Co-local (GM3) 292
Genetic (GM4) 1546
GM Pathway (GM5) 100
Physical (GM6) 38
Predicted (GM7) 29
Shared (GM8) 199
{0, 0.25, 0.5, 0.75, 0.95, 1}. The validation is then carried out for
each of the eight knocked down genes. We thus obtain eight F-
scores, one for the descendants of each KD. These F-scores are
then further assessed by comparing them to F-scores of 1000
random networks.
3.1. PRIOR INFORMATION ONLY
The first step in the assessment of the different prior sources’ qual-
ity is the evaluation of the networks inferred using only these
sources (prior weight w = 1). In Figure 2, we present the results
in terms of F-scores and significance compared to random net-
works. When assessing this figure with respect to the number of
significant results obtained by each prior source, we can observe
that PN performs best with seven out of eight significant results.
The next best prior sources are GM6 and GM5 with six signifi-
cant KDs. With the exception of GM3, all prior sources have at
least two significant results. Furthermore, the F-scores obtained
using prior source PN are amongst the highest values for all KDs
except NGFR. On the contrary, GM6 obtains six significant KDs
but the F-scores are all below those obtained by PN.
Assessing the prior sources’ performance with respect to the
eight knock-downs, it can be observed that some KDs are in gen-
eral better predicted than others. Whilst most prior sources are
able to obtain significant results for HRAS, MAP2K1, MAPK1,
and RAF1, significant results for half the prior sources for CDK5
and MAPK3 they struggle to provide meaningful information for
inference of gene interactions in the context of colorectal cancer
with the remaining two knock-downs (MAP2K2 and NGFR).
3.2. COMBINATION OF DATA AND PRIOR INFORMATION
In this section we assess the networks inferred from genomic
data (KD data in cross-validation; Figure 1) and prior knowledge
with equal weight (w = 0.5). In a first analysis, we compare these
F-scores to those obtained when inferring networks from data
only (w = 0) and from prior knowledge only (w = 1). A statis-
tical test (Wilcoxon rank test) shows that the combination of data
and prior significantly improves the networks (p-values <0.05)
compared to data only (Supplementary Table 1) and prior only
(Supplementary Table 1, with exception of GM2).
In Figure 3, we present these F-scores for each knock-down
and for each of the eight prior sources. For each knock-down, the
results are ordered by F-score values, starting with the best result
and color-coded by prior source. The best prior source for four
out of the eight knock-downs in PN: MAP2K2, MAPK1, MAPK3,
and RAF1. The second highest number of best knock-downs is
reached by GM2: CDK5, HRAS, and MAP2K1. The best prior
source for NGFR is GM4. On the contrary, the performance of
GM3, GM6, and GM7 prior sources is amongst the lowest.
3.3. MOST CONSISTENT PRIOR SOURCE ACROSS THREE DIFFERENT
DATA SETS
In this section, we will show that the results presented in the
previous section for the KD data also hold true when the net-
works are inferred in combination with the two human tumor
data sets. In Table 3, we present the prior source that yielded the
highest F-score for each of the eight knock-downs (prior weight
w = 0.5). This table summarized the results in Supplementary
Figures 9 and 10.
The main observation is that the best prior source is consis-
tent for all three data sets for four of the eight knock-downs:
MAP2K1, MAPK1, MAPK3, and NGFR. For the remaining four
FIGURE 2 | Results when inferring networks with predictionet using only prior knowledge (w = 1). The height of each bar corresponds to the obtained
F -score, colored by prior source. The x-axis specifies the prior source and includes ∗ if the F -score is significant with p-value <0.05 and − for p-values < 0.1.
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FIGURE 3 | Results when inferring networks with predictionet using data and prior knowledge (w = 0.5). The height of each bar corresponds to the
obtained F -score, colored by prior source. The x-axis specifies the prior source and includes ∗ if the F -score is significantwith p-value<0.05 and − for p-values< 0.1.
Table 3 | Best single prior source across three large colorectal cancer
data sets (kd for knock-down experiments in colorectal cancer cell
lines, expO and jorissen for large human colon tumor data) when
combined with microarray gene expression data (prior weight
w = 0.5).
KD KD data expO Jorissen
CDK5 GM2 PN PN
HRAS GM2 GM4 GM2
MAP2K1 GM2 GM2 GM2
MAP2K2 PN PN GM7
MAPK1 PN PN PN
MAPK3 PN PN PN
NGFR GM4 GM4 GM4
RAF1 PN GM8 PN
knock-downs, the best prior source is consistent for two out of
the three data sets: PN for CDK5, MAP2K2, and RAF1 and GM2
for HRAS.
3.4. COMBINING DIFFERENT PRIOR SOURCES
In this section we investigate whether the combination of prior
sources (from a single prior source upto all eight sources) is
beneficial to the quality of the inferred networks. For each knock-
down, we infer a network using the best prior source, then we add
the second best, etc. (Figure 3). We test this procedure on the two
independent human tumor data sets expO and jorissen, the cor-
responding results are presented in Figure 4 and Supplementary
Figure 11, respectively.
When combining expO data and with an increasing number of
prior sources, the results are better than those obtained using only
one source for six out of the eight KDs. For the other two, namely
MAP2K1 and NGFR, we have already observed in section 3.1
that most prior sources are not informative. The number of prior
sources that need to be combined to obtain the highest significant
F-scores depends on the knock-down and range between three
and eight. It is therefore not only important to determine whether
prior sources are relevant by themselves but also which combina-
tion of sources will lead to the best results. Similar observations
can be made for the jorissen data set (Supplementary Figure 11).
4. DISCUSSION
Using the quantitative validation framework we recently intro-
duced in Olsen et al. (2014), we assessed the relevance of dif-
ferent sources of prior information for the inference of large
gene interaction networks from high-throughput gene expres-
sion data sets. Our results suggest that most prior sources,
which include known interactions extracted from research arti-
cles, genetic and physical interactions, co-expression and path-
way databases yield significant networks in colorectal can-
cer when used in isolation. Furthermore, concurring with
our previous results, we demonstrated that the vast majority
of prior sources significantly improves the inference of gene
interaction networks when combined with microarray gene
expression data.
In our case study we showed that priors extracted from
the Predictive Networks web application and the co-expressions
reported in GeneMANIA are the most relevant prior sources in
colorectal cancer as they yield the best networks in our valida-
tion study. We also showed that these results are consistent across
three data sets, composed of a set of knock-down experiments in
colorectal cancer cell lines and large collections of human colon
tumor samples.
As expected, the quality of inferred gene interaction networks
is not uniform over the network topology. For the eight genes
we knocked down to investigate their effects in colorectal cancer
cell lines, we were able to infer statistically significant subnet-
works for most, but not all of them. For instance, we observed
that the effects of NGFR, and MAP2K2 knock-downs are partic-
ularly difficult to model. Interestingly, genetic interactions and
co-expression prior data enabled to build high quality networks
for NGFR, which suggests that priors extracted from diverse
sources are highly complementary.
Our study supports the use of prior information into net-
work inference and we are now working on improving methods
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FIGURE 4 | Results when inferring networks with predictionet
using expO data and prior knowledge (w = 0.5). The height of
each bar corresponds to the obtained F -score, colored by which
prior source was added. The x-axis specifies the prior source and
includes ∗ if the F -score is significant with p-value < 0.05 and −
for p-values < 0.1.
to extract high-quality, context-specific prior information, as
well as developing novel approaches to integrate these priors to
generate better large-scale gene interaction networks. A second
aspect that requires further development is the implementa-
tion of tools to better combine different prior sources with the
hope to significantly improve the local quality of large biological
networks.
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